CN Stock MarketDetailed Quotes
002750 Kunming Longjin Pharmaceutical
- 2.14
- -0.11-4.89%
Market Closed Nov 1 15:00 CST
857.07MMarket Cap-15970P/E (TTM)
2.20High2.14Low169.90KlotVolume2.19Open2.25Pre Close36.61MTurnover4.26%Turnover RatioLossP/E (Static)400.50MShares12.5052wk High1.71P/B853.30MFloat Cap1.4352wk Low2.36Limit Up398.74MShs Float26.32Historical High2.14Limit Down2.67%Amplitude1.43Historical Low--Dividend TTM2.15Avg Price99.80KlotAsk--Div YieldTTM100Lot Size69.70KlotBid
Kunming Longjin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -34.41%46.6M | -9.66%39.42M | 22.43%26.39M | -29.56%86.62M | -30.87%71.05M | -44.14%43.63M | -54.69%21.55M | -82.50%122.97M | -82.69%102.78M | -80.35%78.11M |
| Operating revenue | -34.41%46.6M | -9.66%39.42M | 22.43%26.39M | -29.56%86.62M | -30.87%71.05M | -44.14%43.63M | -54.69%21.55M | -82.50%122.97M | -82.69%102.78M | -80.35%78.11M |
| Other operating revenue | ---- | --428.57K | ---- | -54.57%824.02K | ---- | --0 | ---- | -56.54%1.81M | ---- | -85.92%273.89K |
| Total operating cost | -38.81%66.46M | -17.89%53.74M | 5.39%33.76M | -5.64%153.34M | -9.91%108.6M | -25.14%65.45M | -33.56%32.03M | -77.11%162.5M | -79.72%120.55M | -77.92%87.43M |
| Operating cost | -42.65%12.7M | -16.71%11.01M | 21.45%8.15M | 32.50%33.88M | 21.65%22.14M | -3.21%13.22M | -29.44%6.71M | -94.72%25.57M | -95.70%18.2M | -95.18%13.66M |
| Operating tax surcharges | -36.22%1.6M | -11.14%1.53M | -7.48%788.33K | -9.31%3.22M | -7.10%2.51M | -12.45%1.72M | -17.85%852.07K | -38.58%3.55M | -37.76%2.7M | -32.06%1.96M |
| Operating expense | -39.13%29.63M | -17.11%23.6M | 26.01%17.3M | -19.42%64.73M | -25.21%48.68M | -41.24%28.47M | -50.81%13.73M | -51.35%80.33M | -49.43%65.09M | -43.32%48.46M |
| Administration expense | -25.59%17.44M | -14.03%12.6M | -17.47%5.73M | 5.97%30.52M | 17.31%23.43M | 10.67%14.65M | 15.95%6.95M | -16.52%28.8M | -23.25%19.98M | -22.59%13.24M |
| Financial expense | 42.04%-535.28K | 64.41%-249.87K | 35.29%-209.39K | -77.08%-1.23M | -70.90%-923.55K | -152.75%-702.04K | -197.97%-323.6K | -188.30%-692.63K | -166.71%-540.4K | -177.75%-277.76K |
| -Interest expense (Financial expense) | --179.66K | --127.96K | --4.1K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | 37.56%-612.59K | 43.64%-419.28K | 9.42%-234.02K | -67.82%-1.3M | -63.64%-981.02K | -130.56%-743.98K | -97.34%-258.35K | 31.97%-776.41K | 2.41%-599.5K | 33.91%-322.69K |
| Research and development | -55.92%5.63M | -35.00%5.26M | -51.58%1.99M | -10.94%22.22M | -15.65%12.76M | -22.19%8.09M | 6.44%4.11M | 27.38%24.95M | 30.98%15.13M | 47.67%10.4M |
| Credit Impairment Loss | -1,353.27%-497.53K | -807.43%-1.08M | -25.03%-616.6K | 84.99%-69.81K | -94.77%39.7K | 322.46%152.9K | -403.66%-493.16K | 95.34%-465.14K | 116.66%759.08K | 100.68%36.19K |
| Asset Impairment Loss | 7.58%-63.41K | ---- | 100.07%30.8 | 12.29%-26.5M | ---68.61K | ---68.67K | ---46.18K | -1,347.03%-30.22M | ---- | ---- |
| Other net revenue | 49.34%9.24M | 71.59%6.99M | -20.10%1.18M | 9.23%-15.22M | -48.09%6.19M | -42.05%4.07M | -27.85%1.47M | -922.32%-16.76M | 277.27%11.92M | 1,142.87%7.03M |
| Fair value change income | 48,983.27%4.49M | 17,679.89%4.36M | 298.06%461.9K | 12.97%298.97K | -105.13%-9.18K | -89.14%24.54K | 399.63%116.04K | 332.29%264.65K | 377.92%178.76K | 156.53%225.89K |
| Invest income | -58.04%1.61M | -38.55%1.53M | -46.26%653.68K | -37.21%4.9M | -37.54%3.85M | -36.46%2.48M | -20.12%1.22M | -10.95%7.8M | 13.13%6.16M | 12.96%3.91M |
| -Including: Investment income associates | 25.65%-420K | -11.35%-420K | 38.52%-189.13K | 29.33%-820.97K | 17.31%-564.9K | 33.33%-377.19K | -92.39%-307.62K | 49.89%-1.16M | -5.93%-683.11K | -18.02%-565.75K |
| Asset deal income | ---164.27K | --5.02K | ---- | ---- | ---- | ---- | ---- | -192.57%-177.82K | 240.34%114.82K | 236.11%114.82K |
| Other revenue | 62.56%3.86M | 46.94%2.18M | -0.31%677.87K | 2.13%6.16M | -49.49%2.38M | -46.01%1.48M | 3.72%679.95K | 14.53%6.03M | 76.86%4.7M | 88.20%2.74M |
| Operating profit | 66.16%-10.61M | 58.66%-7.33M | 31.24%-6.19M | -45.53%-81.94M | -435.77%-31.36M | -673.76%-17.74M | -745.28%-9.01M | -931.74%-56.3M | -336.47%-5.85M | -374.48%-2.29M |
| Add:Non operating Income | 112.52%212.8K | 106.50%206.5K | -100.00%0.15 | --100.13K | --100.13K | --100K | 435,819.79%100K | ---- | ---- | ---- |
| Less:Non operating expense | 186,748.22%1.3M | 1,372.08%7.27K | --5.11K | -96.73%406.59K | -99.26%693.65 | -99.47%493.65 | ---- | 10,307.49%12.43M | 41.64%93.87K | 2,505.39%93.87K |
| Total profit | 62.59%-11.7M | 59.56%-7.14M | 30.41%-6.2M | -19.66%-82.24M | -425.64%-31.26M | -639.17%-17.64M | -739.86%-8.91M | -1,135.21%-68.73M | -346.19%-5.95M | -385.50%-2.39M |
| Less:Income tax cost | -24.10%860.22K | -76.52%186.21K | -223.66%-630.36K | -57.92%2.02M | -54.51%1.13M | -62.05%793.13K | -27.39%509.77K | 153.13%4.8M | 391.75%2.49M | 238.02%2.09M |
| Net profit | FPtoL-12.56M | FPtoL-7.32M | FPtoL-5.57M | FPtoL-84.26M | FPtoL-32.4M | FPtoL-18.44M | SL-9.41M | FPtoL-73.53M | SL-8.44M | SL-4.48M |
| Net profit from continuing operation | 61.24%-12.56M | 60.29%-7.32M | 40.88%-5.57M | -14.60%-84.26M | -283.88%-32.4M | -311.81%-18.44M | -1,465.17%-9.41M | -1,307.28%-73.53M | -358.09%-8.44M | -290.48%-4.48M |
| Less:Minority Profit | 43.91%-3.23M | -16.54%-3.1M | 17.19%-1.07M | 23.50%-13.32M | -12.33%-5.75M | -32.23%-2.66M | -809.59%-1.3M | -64.99%-17.41M | -55.07%-5.12M | 20.32%-2.01M |
| Net profit of parent company owners | 64.98%-9.33M | 73.23%-4.22M | 44.66%-4.49M | -26.42%-70.94M | -703.15%-26.64M | -539.60%-15.78M | -1,075.30%-8.12M | -1,914.07%-56.12M | -150.47%-3.32M | -150.62%-2.47M |
| Earning per share | ||||||||||
| Basic earning per share | 64.96%-0.0233 | 73.35%-0.0105 | 44.83%-0.0112 | -26.41%-0.1771 | -701.20%-0.0665 | -535.48%-0.0394 | -1,066.67%-0.0203 | -1,919.48%-0.1401 | -150.61%-0.0083 | -150.82%-0.0062 |
| Diluted earning per share | 64.96%-0.0233 | 73.35%-0.0105 | 44.83%-0.0112 | -26.41%-0.1771 | -701.20%-0.0665 | -535.48%-0.0394 | -1,066.67%-0.0203 | -1,919.48%-0.1401 | -150.61%-0.0083 | -150.82%-0.0062 |
| Other composite income | ||||||||||
| Total composite income | 61.24%-12.56M | 60.29%-7.32M | 40.88%-5.57M | -14.60%-84.26M | -283.88%-32.4M | -311.81%-18.44M | -1,465.17%-9.41M | -885.61%-73.53M | -358.09%-8.44M | -290.48%-4.48M |
| Total composite income of parent company owners | 64.98%-9.33M | 73.23%-4.22M | 44.66%-4.49M | -26.42%-70.94M | -703.15%-26.64M | -539.60%-15.78M | -1,075.30%-8.12M | -1,914.07%-56.12M | -150.47%-3.32M | -150.62%-2.47M |
| Total composite income of minority owners | 43.91%-3.23M | -16.54%-3.1M | 17.19%-1.07M | 23.50%-13.32M | -12.33%-5.75M | -32.23%-2.66M | -809.59%-1.3M | -64.99%-17.41M | -55.07%-5.12M | 20.32%-2.01M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data